Showing 1 - 20 results of 24 for search 'Hogendoorn, P', query time: 0.76s
Refine Results
-
1
The immunophenotype of osteoclasts and macrophage polykaryons by Maggiani, F, Forsyth, R, Hogendoorn, P, Krenacs, T, Athanasou, N
Published 2011Journal article -
2
The immunophenotype of osteoclasts and macrophage polykaryons. by Maggiani, F, Forsyth, R, Hogendoorn, P, Krenacs, T, Athanasou, N
Published 2011Journal article -
3
Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones. by Taylor, R, Kashima, T, Ferguson, D, Szuhai, K, Hogendoorn, P, Athanasou, N
Published 2012Journal article -
4
Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones. by Taylor, R, Kashima, T, Ferguson, D, Szuhai, K, Hogendoorn, P, Athanasou, N
Published 2012Journal article -
5
Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia by Kashima, T, Dongre, A, Flanagan, A, Hogendoorn, P, Taylor, R, Athanasou, N
Published 2011Journal article -
6
Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones by Taylor, R, Kashima, T, Ferguson, D, Szuhai, K, Hogendoorn, P, Athanasou, N
Published 2012Journal article -
7
Smooth muscle actin expression in primary bone tumours. by Hemingway, F, Kashima, T, Mahendra, G, Dhongre, A, Hogendoorn, P, Mertens, F, Athanasou, N
Published 2012Journal article -
8
Smooth muscle actin expression in primary bone tumours. by Hemingway, F, Kashima, T, Mahendra, G, Dhongre, A, Hogendoorn, P, Mertens, F, Athanasou, N
Published 2012Journal article -
9
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. by Hogendoorn, P, Athanasou, N, Bielack, S, De Alava, E, Dei Tos, A, Ferrari, S, Gelderblom, H, Grimer, R, Hall, K, Hassan, B, Hogendoorn, P, Jurgens, H, Paulussen, M, Rozeman, L, Taminiau, A, Whelan, J, Vanel, D
Published 2010Journal article -
10
Lymphatics and bone. by Edwards, J, Williams, K, Kindblom, L, Meis-Kindblom, J, Hogendoorn, P, Hughes, D, Forsyth, R, Jackson, D, Athanasou, N
Published 2008Journal article -
11
A short-term in vivo model for giant cell tumor of bone. by Balke, M, Neumann, A, Szuhai, K, Agelopoulos, K, August, C, Gosheger, G, Hogendoorn, P, Athanasou, N, Buerger, H, Hagedorn, M
Published 2011Journal article -
12
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone. by Balke, M, Campanacci, L, Gebert, C, Picci, P, Gibbons, M, Taylor, R, Hogendoorn, P, Kroep, J, Wass, J, Athanasou, N
Published 2010Journal article -
13
-
14
Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis by Bühnemann, C, Li, S, Yu, H, Branford White, H, Schäfer, K, Llombart-Bosch, A, Machado, I, Picci, P, Hogendoorn, P, Athanasou, N, Noble, J, Hassan, A
Published 2014Journal article -
15
Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. by Romeo, S, Bovée, J, Kroon, H, Tirabosco, R, Natali, C, Zanatta, L, Sciot, R, Mertens, F, Athanasou, N, Alberghini, M, Szuhai, K, Hogendoorn, P, Dei Tos, A
Published 2012Journal article -
16
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma. by Kuijjer, M, Peterse, E, van den Akker, B, Briaire-de Bruijn, I, Serra, M, Meza-Zepeda, L, Myklebost, O, Hassan, A, Hogendoorn, P, Cleton-Jansen, A
Published 2013Journal article -
17
A multidisciplinary approach to giant cell tumors of tendon sheath and synovium--a critical appraisal of literature and treatment proposal. by van der Heijden, L, Gibbons, C, Hassan, A, Kroep, JR, Gelderblom, H, van Rijswijk, C, Nout, R, Bradley, K, Athanasou, N, Dijkstra, P, Hogendoorn, P, van de Sande, MA
Published 2013Journal article -
18
Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer. by Lenos, K, Grawenda, A, Lodder, K, Kuijjer, M, Teunisse, A, Repapi, E, Grochola, L, Bartel, F, Hogendoorn, P, Wuerl, P, Taubert, H, Cleton-Jansen, A, Bond, G, Jochemsen, A
Published 2012Journal article -
19
Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets. by van Oosterwijk, J, Meijer, D, Ruler, v, van den Akker, B, Oosting, J, Krenács, T, Picci, P, Flanagan, A, Liegl-Atzwanger, B, Leithner, A, Athanasou, N, Daugaard, S, Hogendoorn, P, Bovée, J
Published 2013Journal article -
20
The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. by Shalaby, A, Presneau, N, Ye, H, Halai, D, Berisha, F, Idowu, B, Leithner, A, Liegl, B, Briggs, T, Bacsi, K, Kindblom, L, Athanasou, N, Amary, M, Hogendoorn, P, Tirabosco, R, Flanagan, A
Published 2011Journal article